{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:38Z","timestamp":1791341558648,"version":"4.3.1"},"reference-count":6,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>A 43-year-old woman with tubercular choroidal granuloma showed poor response to conventional first-line four-drug antitubercular therapy (ATT) and corticosteroids. A therapeutic trial with intravitreal bevacizumab (1.25\u2005mg in 0.05\u2005mL) injections as an adjunct to ATT and corticosteroids led to a prompt initial regression of granuloma with restoration of visual acuity that was sustained for almost 2\u2005years. A subsequent recurrence of the same lesion with evidence of enhanced vascularity was treated with intravitreal bevacizumab alone, that led to a complete regression of the granuloma with no recurrence until 1\u2005year of follow-up.<\/jats:p>","DOI":"10.1136\/bcr-2013-200255","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T05:01:17Z","timestamp":1378443677000},"page":"bcr2013200255","source":"Crossref","is-referenced-by-count":19,"title":["Intravitreal bevacizumab as an adjunct in the management of a vascular choroidal granuloma"],"prefix":"10.1136","volume":"2013","author":[{"given":"Reema","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Beke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amod","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09273940500269939","article-title":"Successful management of tubercular subretinal granulomas","volume":"2013","author":"Gupta","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.2","doi-asserted-by":"crossref","first-page":"e28383","DOI":"10.1371\/journal.pone.0028383","article-title":"Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis","volume":"2013","author":"Thayil","year":"2011","journal-title":"PLoS ONE"},{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"2013","author":"Via","year":"2008","journal-title":"Infect Immun"},{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)61231-X","article-title":"Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaries development and visual function","volume":"2013","author":"Marneros","year":"2005","journal-title":"Am J Pathol"},{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","article-title":"Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis","volume":"2013","author":"Matsuyama","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2025042709123808000_2013.sep05_1.bcr2013200255.6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2007.11.004","article-title":"Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis","volume":"2013","author":"Husain","year":"2008","journal-title":"J Infect"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:12:42Z","timestamp":1745770362000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":6,"alternative-id":["10.1136\/bcr-2013-200255"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200255","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}